Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Favorable Markman for 749 & 890-hooray

Well if the techie experts on this forum seem to believe that yesterday's Markman ruling was decisively favorable for the 749 & 890, then perhaps the Leckrone's will open up the desk drawer and release a wave of license agreements.

It is a good day for PTSC shareholders. It appears that the big hurdle (336) is looming ahead, however, even if it turns out to be a decisive victory for TPL/PTSC, we still need an announcement from our BoD telling us exactly what their plan is to bring value to shareholders. They need to tell the world the story and ASAP.

Share
New Message
Please login to post a reply